Literature DB >> 2536135

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients.

A Erice1, S Chou, K K Biron, S C Stanat, H H Balfour, M C Jordan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2536135     DOI： 10.1056/NEJM198902023200505

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  75 in total

1.  A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.

Authors:  M L Landry; S Stanat; K Biron; D Brambilla; W Britt; J Jokela; S Chou; W L Drew; A Erice; B Gilliam; N Lurain; J Manischewitz; R Miner; M Nokta; P Reichelderfer; S Spector; A Weinberg; B Yen-Lieberman; C Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Identification of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus.

Authors:  S Keay; T C Merigan; L Rasmussen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 3.  Infectious disease therapy in the 1990s. Where are we heading?

Authors:  M Rozenberg-Arska; M R Visser
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

4.  Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures.

Authors:  J M Pepin; F Simon; A Dussault; G Collin; M C Dazza; F Brun-Vezinet
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

5.  Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro.

Authors:  R Snoeck; G Andrei; D Schols; J Balzarini; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

Review 6.  Resistance of herpesviruses to antiviral drugs.

Authors:  P A Chatis; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

7.  Disseminated cytomegalovirus infection.

Authors:  A Grant; C Sargent; I V Weller; F Scaravilli; L Michaels; R F Miller
Journal:  Genitourin Med       Date:  1992-04

Review 8.  Human cytomegalovirus resistance to antiviral drugs.

Authors:  C Gilbert; G Boivin
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

9.  Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation.

Authors:  R Mañez; S Kusne; M Green; K Abu-Elmagd; W Irish; J Reyes; H Furukawa; A Tzakis; J J Fung; S Todo
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

10.  Human cytomegalovirus UL97 kinase confers ganciclovir susceptibility to recombinant vaccinia virus.

Authors:  C Metzger; D Michel; K Schneider; A Lüske; H J Schlicht; T Mertens
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.